Literature DB >> 19176284

IL-18 gene polymorphism and metabolic syndrome.

I Presta, F Andreozzi, E Succurro, M A Marini, E Laratta, R Lauro, M L Hribal, F Perticone, G Sesti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19176284     DOI： 10.1016/j.numecd.2008.10.002

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN： 0939-4753            Impact factor:   4.222


× No keyword cloud information.
  12 in total

1.  IL-4 and IL-6 levels and adipose tissue distribution in HIV-1 patients under antiretroviral therapy.

Authors:  S Belo; A C Santos; A Madureira; J Pereira; A Sarmento; D Carvalho; P Freitas
Journal:  J Endocrinol Invest       Date:  2015-02-27       Impact factor: 4.256

2.  Interleukin-18 null mutation increases weight and food intake and reduces energy expenditure and lipid substrate utilization in high-fat diet fed mice.

Authors:  Eric P Zorrilla; Bruno Conti
Journal:  Brain Behav Immun       Date:  2013-12-06       Impact factor: 7.217

Review 3.  IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance.

Authors:  Dov B Ballak; Rinke Stienstra; Cees J Tack; Charles A Dinarello; Janna A van Diepen
Journal:  Cytokine       Date:  2015-07-17       Impact factor: 3.861

Review 4.  The role of interleukin-18 in the metabolic syndrome.

Authors:  Marius Trøseid; Ingebjørg Seljeflot; Harald Arnesen
Journal:  Cardiovasc Diabetol       Date:  2010-03-23       Impact factor: 9.951

5.  The frequency of an IL-18-associated haplotype in Africans.

Authors:  Simon R Thompson; Steve E Humphries; Mark G Thomas; Rosemary Ekong; Ayele Tarekegn; Endeshaw Bekele; Olivia Creemer; Neil Bradman; Krishna R Veeramah
Journal:  Eur J Hum Genet       Date:  2012-08-29       Impact factor: 4.246

6.  Characterization of Wnt1-inducible Signaling Pathway Protein-1 in Obese Children and Adolescents.

Authors:  An-Ru Wang; Xue-Qin Yan; Cai Zhang; Cai-Qi Du; Wen-Jun Long; Di Zhan; Jie Ren; Xiao-Ping Luo
Journal:  Curr Med Sci       Date:  2018-10-20

7.  Circulating interleukin-18: A specific biomarker for atherosclerosis-prone patients with metabolic syndrome.

Authors:  Minako Yamaoka-Tojo; Taiki Tojo; Kazuki Wakaume; Ryo Kameda; Shinji Nemoto; Naonobu Takahira; Takashi Masuda; Tohru Izumi
Journal:  Nutr Metab (Lond)       Date:  2011-01-20       Impact factor: 4.169

8.  Genetic variation within IL18 is associated with insulin levels, insulin resistance and postprandial measures.

Authors:  M C Smart; G Dedoussis; N Yiannakouris; M L Grisoni; G K Dror; M Yannakoulia; C Papoutsakis; E Louizou; C S Mantzoros; L Melistas; M D Kontogianni; J A Cooper; S E Humphries; P J Talmud
Journal:  Nutr Metab Cardiovasc Dis       Date:  2010-03-12       Impact factor: 4.222

Review 9.  Interleukin 18 and coronary heart disease: prospective study and systematic review.

Authors:  Barbara J M H Jefferis; Olia Papacosta; Christopher G Owen; S Goya Wannamethee; Steve E Humphries; Mark Woodward; Lucy T Lennon; Andrew Thomson; Paul Welsh; Ann Rumley; Gordon D O Lowe; Peter H Whincup
Journal:  Atherosclerosis       Date:  2011-03-24       Impact factor: 5.162

10.  Circulating levels of IL-18 are significantly influenced by the IL-18 +183 A/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an observational study.

Authors:  Trine B Opstad; Alf Å Pettersen; Harald Arnesen; Ingebjørg Seljeflot
Journal:  Cardiovasc Diabetol       Date:  2011-12-05       Impact factor: 9.951
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.